Fouad Namouni
Chief Tech/Sci/R&D Officer at BLUEPRINT MEDICINES CORPORATION
Net worth: 3 M $ as of 2024-04-29
Profile
Dr. Fouad Namouni, MD, is a President-Research & Development at Blueprint Medicines Corp. and an Independent Director at Aprea Therapeutics, Inc. He is on the Board of Directors at Aprea Therapeutics, Inc. Dr. Namouni was previously employed as a Head-Oncology Development by Bristol Myers Squibb Co.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-30 | 27,564 ( 0.05% ) | 3 M $ | 2024-04-29 | |
VOR BIOPHARMA, INC.
-.--% | 2024-05-22 | 0 ( -.--% ) | - $ | 2024-04-29 |
Fouad Namouni active positions
| Companies | Position | Start |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | 2020-08-31 |
| VOR BIOPHARMA INC. | Director/Board Member | 2024-04-29 |
Former positions of Fouad Namouni
| Companies | Position | End |
|---|---|---|
| APREA THERAPEUTICS, INC. | Director/Board Member | 2022-05-15 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
Training of Fouad Namouni
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| APREA THERAPEUTICS, INC. | Health Technology |
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| VOR BIOPHARMA INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Université de Paris XI Paris Sud | Consumer Services |
| Université de Paris 5 René Descartes | Consumer Services |
- Stock Market
- Insiders
- Fouad Namouni
